SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-24-013553
Filing Date
2024-04-29
Accepted
2024-04-29 16:16:09
Documents
1
Period of Report
2024-04-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 5223
  Complete submission text file 0001127602-24-013553.txt   6941
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Issuer) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CAVA GROUP, INC. 14 RIDGE SQUARE NW, SUITE 500 WASHINGTON DC 20016
Business Address
Amouyal Philippe (Reporting) CIK: 0001376854 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30111 | Film No.: 24890997